Abstract. In modeling the inflammatory response to a lesion in an artery wall, there are a number of chemotactic mechanisms going on within the wall layer that lead to an arterial plaque. We introduce a rather reduced model of these dynamic processes, but the focus of this paper is a subsystem of the full model system that has independent interest. Namely, the system here consists of two cell densities, each producing a chemical that is a chemoattractant for the other cell type. Then we prove positivity, local and global existence, and discuss some qualitative behavior of solutions.
Introduction
The following investigation came out of a project to model the development of an atherosclerotic plaque, and specifically to follow the development of the plaque's fibrous cap and its possible degradation. This led to a sub model of the form
along with initial conditions At t = 0 :
Here u and v represent two different types of cell densities within an arterial cell layer, the intima, which we denote rather arbitrarily by 0 < x < 1. Also, u 0 ≥ 0, v 0 ≥ 0, a 0 ≥ 0, b 0 ≥ 0 on domain x ∈ [0, 1]. So system (1) is defined on domain Ω T = {(x, t) : 0 < x < 1 , 0 < t < T }. Cell type v (respectively, u) produces a chemoattractant chemical a (resp. b) for cell type u (resp. v), with chemoattractant affinities (positive constant) parameters being α 1 and α 2 . All the theoretical work the authors are aware of, whether in one or higher space dimensions, has involved a single cell type producing the chemoattractant concentration ("self-chemotaxis"). A feature not usually included in chemotaxis models is the addition of a death term for u, death rate µ > 0, and a proliferation term for v, namely a (Verhulst) growth rate, where the intrinsic growth parameter ρ depends on the chemoattractant b.
For the boundary conditions, let At x = 0: a x = b x = 0 ; so u x = 0 and −v x = h(b(0, t))
At x = 1: a x = b x = 0 ; so u x = g(t) and v x = 0 0 ≤ t ≤ T
More details on the functions ρ, f, h, and g will be given below. The original goal in considering this system was to understand if the modeling allowed the two cell densities to concentrate near x = 1 where the fibrous cap, which separates the plaque from the blood, develops. Figure 1 gives an example case of a numerical solution that does just that.
There is a large and growing literature on the analysis of chemotaxis systems. A couple of good review articles, though slightly dated, are Horstmann [8] and Hillen and Painter [5] . See also the books of Perthame [15] and Suzuki [16] . Global existence for 1D models was accomplished by Osaki and Yagi [12] . For higher space dimensions, various global results are in, for example, Horstmann [7] , Gajewski and Zacharias [4] , Biler [3] , Wrzosek [18] , and Hillen and Potapov [6] . These contributions all involve a single cell population and single chemoattractant, and often have homogeneous Neumann or Dirichlet boundary conditions. A notable exception is the early work of Lauffenburger, et al [10] , which has a kinetic term on the cell concentration equation, and nonlinear boundary conditions. While most chemotaxis models do not include death or kinetic terms for cell populations, a few that do include Painter and Hillen [14] , Little, et al [11] , Osaki, et al [13] , and Wrzosek [18] , and the previously mentioned work of Lauffenburger, et al [10] (and follow-on work of Wang [17] and Zeng [19] ). Our model here, besides having two cell types and two "cross-chemoattractants", has a nonlinear kinetic term and nonlinear boundary conditions. Our system can be put into Amann's 'separated divergence form' (see Amann [1] ); so a local (smooth) solution can be obtained this way, but we chose an alternative fixed-point approach. Our existence results are closest in flavor to that of Hillen and Potapov [6] , though our analysis differs significantly. Also, our system seems to have most of the characteristics of Amann's normally elliptic systems (Amann [2] ), but we elected not to pursue that approach to global existence.
In the next section we mention some background leading to problem (1)-(3). The sections after that will concern analysis of the crosschemotaxis model (1) , and a future paper will consider the analysis of the full plaque model. Section 3 is concerned with local existence of a solution, while section 4 deals with positivity of solutions. Section 5 develops global bounds on the solution and hence a global solution, then we discuss more formal qualitative solution behavior in section 6. The final section will discuss possible extensions and their relevance to other physical problems.
Outline of Model Development
Arteries are layered structures with the inner basal membrane contacting the blood made of endothelial cells, followed outwardly by the intima layer, then the media layer, and finally external layers of more structural material. An arterial plaque is a lesion that develops in the intima layer. It is made up of immune cells, cell debris, lipids, fibrous connective tissue, etc. Arterial plaque formation and growth involves complex chemical, hemodynamic, and biomechanics processes. There are basically two types of plaques. Stable plaques that mainly cause no detrimental clinical effects, unless it becomes sufficiently large to compromise blood flow. Then there are unstable, or vulnerable, plaques that are high risk of rupturing and causing thrombosis. The latter plaques generally have larger lipid cores and thinner fibrous caps than stable plaques. We are interested in why some plaques develop into vulnerable plaques, and the modeling has concentrated on plaque processes that couple to cap dynamics. Plaque vulnerability is tied directly to degradation of the fibrous cap, and we believe a one space dimensional model is sufficient to address this issue.
Our biological model considers some principal chemical processes, neglecting the hemodynamic and most of the biomechanical processes, the endothelial layer mechanisms, plaque growth aspects, and the complex three-dimensional geometry. It primarily investigates mechanisms for migration of smooth muscle cells and immune cells (macrophages) toward the endothelial layer, which provide critical extracellular matrix material, mainly collagen, to build the cap, and chemicals that tend to degrade the cap. † Chemoattractant activity is important to this fibrous cap development. There is production of macrophage chemoattractants, like chemotactic peptide-1, from smooth muscle cells, and production of growth factors, like PDGF-B, from macrophages that play a role in smooth muscle cell migration and proliferation within the plaque. A full discussion of the model development, with analysis, will be done elsewhere. Our interest here is the analysis of the above (sub)model involving two cell types, macrophage population represented by the scaled u variable, and smooth muscle cells, represented by v, and two chemoattractants, a and b.
Existence of a Local Solution
We will now state the assumptions.
( 
Notation:
The norm · will always denote the L 2 norm with respect to the space variable x . Also, ·, · will be the inner product. Furthermore, in all the computations below, C will denote a generic, time independent constant, which may depend on the parameters indicated above but not on the initial data, and whose value may change from one line of the computation to the next. 
with homogeneous Neumann boundary conditions, and define
Let
Assume that sup 0<t≤T max a (n−1) 2
We will prove that the same bounds hold for ( (4) and integrating by parts, we obtain 1 2
whence, using Young's inequality, we get
From (9), we obtain
Thus, by Gronwall's inequality, we arrive at
Inserting this bound in (9) and integrating, we get
provided T is sufficiently small, which in turn also implies
The computation for b (n) is similar. †
We will now obtain analogous estimates for u (n) , v (n) . Taking L 2 -inner product of (6) with u (n) and integrating by parts we obtain
Note that
where x y denotes x ≤ Cy for an adequate constant C > 0. The last inequality in the line above is obtained using Young's inequality where a suitable adjustment of constant is made in the application of Young's inequality so that the term u
where we used Young's inequality ab ≤
, 1/p + 1/q = 1 with p = 4/3, q = 4. Using the above two estimates in (10), we obtain 1 2
First dropping the term
2 from the inequality (11) and applying Gronwall's inequality, we obtain
where the last inequality holds provided T is sufficiently small, where the size of T ≤ T depends only on K and
note that due to
. Choose T sufficiently small so that e CK 2 T ≤ 2
). Now inserting this bound for u (n) 2 in (11) and integrating again we obtain
provided T is adequately small. Once again, the size of T that is permissible depends only on K and T 0 g 2 (s). In other words, provided T ≤ T is adequately small (depending only on the initial data through K and T 0 g 2 (s)), the estimate (8) is satisfied for all n. The estimate for v (n) follows in a similar manner. Next we show that (a
) forms a convergent sequence with respect to the norm
in fact it forms a contractive sequence for T adequately small. To that end, denoteâ (n) = a (n) − a (n−1) and similarly for b, u and v. From (4), it follows that
As before, we obtain 1 2
which in turn implies
Thus, {a (n) } forms a contractive sequence in H 1 provided T is small (i.e. provided, for instance, if CT e 2µaT ≤
4
). The proof for {b (n) } is similar.
Consider nowû (n) . We havê
Similarly,
Inserting the estimates (13) and (14) in (12) and recalling thatû (n) 0 = 0, we obtain using Gronwall inequality
In view of (8),
Thus, provided T is small (the size of T may depend on K but not on n), we have
A similar estimate holds also forv (n) where we also need to make use of the fact that ρ and f are uniformly Lipschitz. To see this, note that as in (12), we have
Using the global Lipschitz property and uniform bound on ρ, f , we have
Using this observation and following calculations similar to the ones which yield (15) starting from the equality in (12), we arrive at
starting from (16) . Thus, we have the final estimate In what follows, we will omit the limits of integration as it will be inferred from context. All integrals with respect to the space variable will be on the interval [0, 1]. First observe that
We use equivalent expressions to these for v, a, b below. Taking L 2 − inner product of the u equation in (1) with u − , integrating by parts and using (17), we get 1 2
Using the boundary conditions (3), we have α 1 ua x u − | x=1 x=0 = 0 and 
where, to obtain the last inequality, we used Young's inequality
Note now that in space dimension one, we have the inequality a x L ∞ a H 2 . Moreover, by the regularity property of the local solutions, † T 0 a 2 H 2 ds < ∞. Using Gronwall inequality, we have
It readily follows that u ≥ 0 for all t > 0 provided u 0 ≥ 0 (or equivalently, (u 0 ) − = 0).
Positivity of
Note that due to the fact that h ≥ 0, we have
Using b x L ∞ b H 2 and Gronwall inequality, we deduce as before
It readily follows that v ≥ 0 for all t > 0 provided v 0 ≥ 0 (or equivalently, (v 0 ) − = 0).
Positivity of a, b. From the b equation in (1) we get
Integrating by parts and using the equivalent expressions to (17) for b, we obtain 1 2
Note that the homogeneous Neumann boundary condition for b implies that b x b − | x=1 x=0 = 0. Furthermore, we have shown that u ≥ 0 if u 0 ≥ 0, which in turn yields ub − ≤ 0. Consequently,
In particular, this implies that if b 0 ≥ 0 a.e., (equivalently, (b 0 ) − = 0 a.e.), then b(x, t) ≥ 0 a.e.. Proceeding in a similar manner and using the fact that v ≥ 0 a.e. we can deduce that a ≥ 0 a.e.
Global Bounds and Global Solutions on Ω T
We will need the following Gagliardo-Nirenberg inequalities to proceed:
Proceeding as before, and using (3) and the inequality (18c), we get 1 2
where in the last line we used (18b) to bound u L 4 and (18a) to bound a x L 4 . Using Young's inequality, we obtain
Consequently, from the inequality above and (19), we obtain 1 2
Proceeding in a similar manner, from the b equation we obtain 1 2
where in the very last line, we also used Young's inequality. Thus, we get
Differentiating the a and b equations with regard to x yields
Taking L 2 inner product of (22a) with a x , integrating by parts in the integral a xxx a x and using the boundary conditions a x = 0 for x = 0, 1, we get 1 2
where to obtain the very last inequality, we used Young's inequality
Similarly from (22b) we obtain 1 2 
Thus, global existence will immediately follow from (25) provided one can show, for every T > 0,
where the constants C T ,C T may depend on the initial data, the parameters, and T , but are independent of the solution. Indeed, assume that [0, T ) is the maximal interval of existence of weak solutions with the regularity properties mentioned in the previous section with T < ∞.
We will establish that in such a case, (26a) holds. Thus, if we can show that (26b) also holds, then the solution can be continued and there is no blow-up, i.e. T = ∞. In other words, if (26b) holds, then the solution can be continued further contradicting the fact that [0, T ) is the maximal interval of existence. Our next goal is to establish (26). We will first establish (26a). Note that due to the non-negativity of u, v, a, b, u L 1 = udx; a similar relation holds for each v, a, b.
, where the last equality holds due to nonnegativity of u. By taking inner product with the constant function 1 and integrating by parts in the u equation, and using the boundary conditions, we have
It follows immediately that
and (26a) immediately follows concerning u. Concerning b, proceeding in a similar manner, we have the equation
Using the uniform estimate for u L 1 just obtained, it readily follows that sup
Similarly, we can deduce (26a) for v, a.
We now proceed to prove the uniform e.g. [6] ) we have is
Thus,
Denote F (s) = β 1 v(s) − µ a a(s) and note that due to (26a),
Using (27) we immediately obtain
where we have also used the fact that S(t)a 0 H 1 ≤ C a 0 H 1 , where C is independent of T .
Further Remarks on Solutions, a Formal
Perturbation, and Numerical Solutions
Since the full arterial plaque model, from which the system analyzed here, is concerned with the development and possible degradation of a fibrous cap associated with the plaque, our interest in the qualitative behavior of our solution is to have u and v aggregate near the boundary x = 1 as t gets large. We indicate such behavior via a formal perturbation argument and a numerical simulation, but first we consider the dynamics of the average concentrations. u(x, t)dx, and similarly for the variables v, a, b. Then, from averaging the equations in (1) and using the boundary conditions (3), we have (
Observe first that
This, if
∞ 0 g 2 < ∞, we have the time invariant bound
Now denoting by ū the difference of the averages of two solutions, we obtain d dt ū(t) = −µ ū(t), which in turn yields ū(t) = e −µt ū(0).
In particular, together with the time invariant bound obtained above, this meansū(t) →ū c for some 0 ≤ū c < ∞. † Similarly, using the fact thatū(t) is uniformly bounded in time, it readily follows that sup t≥0b (t) < ∞. Moreover, denoting b the difference of the average of two solutions, we have
Using (28), we readily obtain an explicit solution
This immediately yields that b (t) → 0 as t → ∞. Together with the time uniform bound forb(t), it follows as before thatb(t) →b c as t → ∞, where 0 ≤b c < ∞.
For theā andv case, let h M > 0 and
for t ∈ (0, T ), and
The above arguments lead us to the intriguing possibility that the averagesā(t) andv(t) can increase polynomially in t whileū,b converge to a finite number as t → ∞. A detailed analysis of the asymptotic behavior of the entire system in relation to the physical (biological) parameters and its biological consequences will be explored in a future work.
6.2. A Formal Perturbation. Now we indicate in an informal way that the variables do what they are supposed to do physically, that is, they "stack" up next to the boundary x = 1. For this we scale problem (1) and consider the long time behavior as a perturbation problem, and then show a numerical solution to the system. For purposes of the calculations below we make a few more assumptions. First, we consider the original spatial domain as 0 < x < L, which provides a convenient length scale. Next, we consider the 'linearized' problem in that we assume f (v) = ρ 0 v, and let ρ be a constant. Let (U, V, A, B) be characteristic values for (u, v, a, b), soũ = u/U , etc., and define dimensionless variablesx = x/L,t = t/T . Assume D 4 = D 3 , and for some constant k > 0,
. These parameters will be considered order one. We also consider the case where k is sufficiently large compared to µ or ρ ("slow" cell migration in the intima), that the scaled µ and ρ are small; that is, εμ = µT , and ερ = ρT , where 0 < ε << 1. Then, considering only the steady state case (and dropping the tilde notation), we have the system
with boundary conditions
where we assume lim t→∞ g(t) = Q exists. This is a regular perturbation problem, so the solution is analytic in ε. Writing u ∼ u 0 + εu 1 + . . ., with analogue expansions for v, a, b, the order one problem is
One way of writing the solution is (29) is given by the solution of the lowest order problem, and with positivity of u(0) and v(0), and knowing the formulas for the Green's functions G(x, s) and G(x, s), we
This is all consistent with these cells and chemicals piling up at the boundary x = 1. If the flux of u(x, t) at x = 1 becomes zero for t greater than some T > 0, then Q = 0. It is likely that b(0) is negligible, and since h(0) = 0, then these conditions given homogeneous Neumann boundary conditions for system (29). For purposes of this next calculation, assume small chemical decay terms; that is, replace parameters µ a , µ b with εµ a , εµ b . Then, instead of problem (31), we have for the lowest order problem
With our Neumann boundary conditions, u 0 − ∆u 0 a 0 = 0, so u 0 = Ce ∆a 0 , for some constant C. Similarly, v 0 = De Γb 0 for some constant D. Substituting into (33), we have
Again assume ε << 1 so all the interesting steady state behavior is contained in the lowest order terms. For convenience drop the "0" subscript notation. Write
That is, b e Γb = Ka e ∆a , where 
R Γ e −Γb = P , which we assume is a positive constant. Therefore, b = ± 2(P − (R/Γ)e −Γb ), or
(and the same for v 0 ), so u 0 , v 0 have the same qualitative graph as a 0 and b 0 have, with their maximum at x = 1. Figure 1 also shows the concentrations of u and v evolve to the boundary x = 1 that represent the boundary between the intima layer of the artery, and the lumen (central blood flow region).
Discussion
The present analysis of this cross-chemotaxis system is the core of a more extensive model system for an arterial (atherosclerotic) plaque model, whose modeling goal is to determine a quantitative understanding of plaque vulnerability mechanisms. However, the system analyzed here should have independent interest since it has potentially a richer pattern formation structure, than the single cell, single chemical ("auto-chemotaxis") case, particularly in higher space dimensions. If, upon scaling our model, some parameters are relatively small compared to other parameters, this would open opportunity to do some perturbation analysis on the system.
A particular modeling assumption we made was to keep the chemoattractant terms of the simplest Keller-Segel kind. In our biological situation, the chemicals tend to bind to cell surface receptors, and a more general form of chemoattractant mechanism might be more appropriate. For example, we could replace the α 1 ua x (respectively, α 2 vb x ) term by α 1 uB 1 (a)a x (respectively, α 2 vB 2 (b)b x ). At the present time we do not have the data to determine what form the B 1 (·) and B 2 (·) would take.
In the full arterial plaque model some accounting of fluid shear stress on the endothelial cell layer separating the blood from the plaque will be considered. This is because differences in shear stress trigger different chemical pathways in the endothelial cells that have a measurable effect on chemical interactions at the boundary of the plaque. In the simplest scenario concerning system (1), accounting for this external signal would require modification of the boundary conditions for a and b at x = 1 to be non-homogeneous flux conditions depending on the strength of the signal, which in turn leads to Robin boundary conditions for u and v at x = 1. We have not explored this modification yet.
Another aspect of arterial plaque modeling is that many more chemoattractants are present in the plaque, along with other cell types. In a more detailed model formulation, foam cells and T-lymphocytes, for example, should be accounted for. These, along with endothelial cells, and not just smooth muscle cells and macrophages, produce chemicals that affect the migration, motility, and proliferation of various cell populations. A similar observation can be made in various inflammation studies and in wound healing modeling. Hence, we have formulated a model system involving an arbitrary number of cell populations and an arbitrary number of chemical attractants, and we will analyze the system in a future paper.
Last, but not least, plaques are three dimensional, and exploration of such cross-chemoattractant problems discussed here needs to be carried over to higher dimensions when the questions being asked needs such a generalization.
